Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xoma Corp 8.625% (NQ: XOMAP ) 25.46 +0.16 (+0.61%) Streaming Delayed Price Updated: 9:35 AM EDT, Jun 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 400 Open 25.41 Bid (Size) 25.31 (5) Ask (Size) 25.52 (3) Prev. Close 25.31 Today's Range 25.41 - 25.46 52wk Range 21.40 - 25.98 Shares Outstanding N/A Dividend Yield 8.47% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News XOMA Declares Quarterly Preferred Stock Dividends June 20, 2024 From XOMA Corporation Via GlobeNewswire XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher June 12, 2024 From XOMA Corporation Via GlobeNewswire Performance YTD -1.11% -1.11% 1 Month +0.61% +0.61% 3 Month +0.33% +0.33% 6 Month -0.14% -0.14% 1 Year +5.27% +5.27% More News Read More XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ May 14, 2024 From XOMA Corporation Via GlobeNewswire XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities May 09, 2024 From XOMA Corporation Via GlobeNewswire XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2% April 30, 2024 From XOMA Corporation Via GlobeNewswire XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) April 25, 2024 From XOMA Corporation Via GlobeNewswire XOMA Corporation Announces Closing of Tender Offer April 03, 2024 From XOMA Corporation Via GlobeNewswire XOMA Declares Quarterly Preferred Stock Dividends March 21, 2024 From XOMA Corporation Via GlobeNewswire XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. March 19, 2024 From XOMA Corporation Via GlobeNewswire XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value March 08, 2024 From XOMA Corporation Via GlobeNewswire XOMA to Present at Upcoming Investor Conferences in March February 28, 2024 From XOMA Corporation Via GlobeNewswire XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right February 16, 2024 From XOMA Corporation Via GlobeNewswire XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition January 18, 2024 From XOMA Corporation Via GlobeNewswire FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx January 11, 2024 From XOMA Corporation Via GlobeNewswire XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors January 08, 2024 From XOMA Corporation Via GlobeNewswire XOMA Announces Stock Repurchase Program of up to $50 Million January 02, 2024 From XOMA Corporation Via GlobeNewswire XOMA Declares Quarterly Preferred Stock Dividends December 20, 2023 From XOMA Corporation Via GlobeNewswire XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties December 19, 2023 From XOMA Corporation Via GlobeNewswire XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value November 07, 2023 From XOMA Corporation Via GlobeNewswire XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) October 31, 2023 From XOMA Corporation Via GlobeNewswire XOMA Declares Quarterly Preferred Stock Dividends September 25, 2023 From XOMA Corporation Via GlobeNewswire XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From XOMA Corporation Via GlobeNewswire XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy August 08, 2023 From XOMA Corporation Via GlobeNewswire XOMA Added to the Russell 2000® and Russell 3000® Indexes June 23, 2023 From XOMA Corporation Via GlobeNewswire XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset June 22, 2023 From XOMA Corporation Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
